For US Residents Only
What to Expect When Taking PLUVICTO
Before treatment with PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)
A PSMA PET scan will check for PSMA+ cancer in your body
If you have already been treated with other anticancer treatments and your doctor determines that PLUVICTO is an appropriate treatment, he/she will refer you to a radiation oncologist or nuclear medicine treatment facility to receive PLUVICTO.
- A team of doctors will be working together to manage care of your PSMA+ metastatic castration-resistant prostate cancer
- Laboratory tests will be performed within 3 days before your first treatment with PLUVICTO
During treatment with PLUVICTO
PLUVICTO is given once every 6 weeks for up to 6 treatments, depending on how your body responds to the treatment
After treatment with PLUVICTO
Be sure to follow instructions given by your health care provider.
PSMA+, prostate-specific membrane antigen positive.